FACT-Taxane Questionnaire

Known as: FACT-Tax Questionnaire, FACT-Taxane, Functional Assessment of Cancer Therapy-Taxane 
A subscale complement to the FACT-G developed specifically for evaluating the potential side effects of taxane therapy on cancer patients.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2018
024619962018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
BACKGROUND No validated disease-specific questionnaires exist to capture health-related quality of life (HRQoL) in patients with… (More)
  • table 1
  • table 2
  • table 3
  • table 6
Is this relevant?
2016
2016
The purpose of this study was to investigate the impact of hospital type determined at primary treatment and find possible… (More)
Is this relevant?
2016
2016
Introduction Thefindingspresentedduringthe2016AmericanSociety ofClinicalOncology(ASCO)meetingwill furtheradvance our… (More)
Is this relevant?
2014
2014
This study was aimed at using proximity ligation assay (PLA) followed by enzyme-linked immunosorbent assay (ELISA) to identify… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2011
Review
2011
Despite the proven success of hormonal therapy for prostate cancer using chemical or surgical castration, most patients… (More)
  • table 1
Is this relevant?
Review
2009
Review
2009
e20709 Background: Quality of life (QoL) assessment in clinical trials has been gaining more attention. FACT-G surveys have been… (More)
Is this relevant?
2008
2008
In Her2/neu growth factor overexpressing poor prognosis breast cancers trastuzumab has shown to improve disease-free survival as… (More)
  • figure 1
Is this relevant?
2008
2008
Die Behandlung des hereditären Mammakarzinoms unterscheidet sich bislang nicht von der des sporadischen Mammakarzinoms. Es gibt… (More)
Is this relevant?
2004
2004
PURPOSE Combination therapy consisting of an oral taxane, BMS-275183, and the anti-epidermal growth factor receptor monoclonal… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2004
2004
817 Background: The combination of vinorelbine (N) and capecitabine (C) has demonstrated to be active and safe regimen for… (More)
Is this relevant?